| Not Yet Recruiting | Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by F NCT07506967 | Kenya Medical Research Institute | N/A |
| Not Yet Recruiting | Better Options for Lymphatic Filariasis Treatment NCT07159373 | Medicines Development for Global Health | Phase 3 |
| Recruiting | Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910 | Institut Pasteur du Cambodge | — |
| Unknown | Adjunctive Ivermectin Mass Drug Administration for Malaria Control NCT04844905 | London School of Hygiene and Tropical Medicine | Phase 3 |
| Completed | Moxidectin for LF, Cote d'Ivoire (DOLF) NCT04410406 | Washington University School of Medicine | Phase 3 |
| Unknown | Spontaneous Antigenemia in Loiasis NCT04258670 | Washington University School of Medicine | — |
| Completed | A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India NCT02929121 | The Task Force for Global Health | Phase 3 |
| Completed | PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs ) NCT03664063 | Lihir Medical Centre | Phase 2 |
| Completed | A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali NCT02927496 | The Task Force for Global Health | Phase 3 |
| Completed | A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka NCT02929134 | The Task Force for Global Health | Phase 3 |
| Completed | Twice Yearly Treatment for the Control of LF NCT03036059 | Noguchi Memorial Institute for Medical Research | Phase 4 |
| Completed | Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis NCT02899936 | Washington University School of Medicine | N/A |
| Completed | Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study NCT02509481 | Colorado State University | Phase 2 / Phase 3 |
| Completed | Lymphatic Filariasis (LF) in Ivory Coast NCT02974049 | University Hospitals Cleveland Medical Center | N/A |
| Completed | Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside NCT01975441 | University Hospitals Cleveland Medical Center | Phase 2 |
| Completed | Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocercias NCT02032043 | Washington University School of Medicine | — |
| Withdrawn | Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis NCT01903057 | Emory University | Phase 4 |
| Completed | Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in P NCT03268252 | University Hospitals Cleveland Medical Center | — |
| Completed | Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India NCT01629771 | Northwestern University | — |
| Completed | Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia NCT01905436 | Washington University School of Medicine | — |
| Completed | Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocercias NCT01905423 | Washington University School of Medicine | — |
| Terminated | Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi NCT01213576 | London School of Hygiene and Tropical Medicine | N/A |
| Completed | Effect of Albendazole Dose on Treatment of Lymphatic Filariasis NCT00511004 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Research for Elimination of Lymphatic Filariasis (ICIDR) NCT00406627 | Washington University School of Medicine | — |
| Completed | Effect of Albendazole Dose on Clearance of Filarial Worms NCT00375583 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Effect of Albendazole Dose on Clearance of Filarial Worms NCT00339417 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Interaction Between HIV and Lymphatic Filariasis NCT00295698 | DBL -Institute for Health Research and Development | N/A |
| Completed | Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali NCT02784743 | Centre d'Appui à la lutte contre la Maladie | Phase 4 |